THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 1 filers reported holding THERAVANCE BIOPHARMA INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MASSMUTUAL TRUST CO FSB/ADV | 42 | $472 | 0.00% |
External links
This page lists THERAVANCE BIOPHARMA INC's shareholders in Q4 2023. To view THERAVANCE BIOPHARMA INC's shareholder history, click here.